Form D — GT Biopharma, Inc.
0001641172-25-012695 · filed 2025-05-28
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $20,000,000
- Total sold
- $0
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- GT Biopharma, Inc.
- CIK
- 109657
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 505 MONTGOMERY STREET
SAN FRANCISCO, CA 94111 - Phone
- 800-304-9888
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Michael Breen · Executive OfficerSAN FRANCISCO, CA Find on LinkedIn ↗
-
Alan Urban · Executive OfficerSAN FRANCISCO, CA Find on LinkedIn ↗
-
Charles Casamento · DirectorSAN FRANCISCO, CA Find on LinkedIn ↗
-
Hilary Kramer · DirectorSAN FRANCISCO, CA Find on LinkedIn ↗
-
Andrew Ritter · DirectorSAN FRANCISCO, CA Find on LinkedIn ↗
View original on SEC EDGAR.